Literature DB >> 33398

CNS effects of the antihistamines diphenhydramine and terfenadine (RMI 9918).

M Fink, P Irwin.   

Abstract

The quantitative EEG profile of a putative antihistaminic drug, terfenadine, was determined in a crossover comparison with diphenhydramine in normal male volunteers. Terfenadine failed to elicit the characteristic EEG or behavioral effects of sedative antihistaminics, and was distinguishable from diphenhydramine. The EEG profile confirmed the lack of CNS effect observed in preclinical and clinical trials.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 33398     DOI: 10.1055/s-0028-1094592

Source DB:  PubMed          Journal:  Pharmakopsychiatr Neuropsychopharmakol        ISSN: 0031-7098


  13 in total

1.  Treatment of pruritus due to chronic obstructive liver disease.

Authors:  J S Duncan; H J Kennedy; D R Triger
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-07

Review 2.  Terfenadine. The first nonsedating antihistamine.

Authors:  H C Masheter
Journal:  Clin Rev Allergy       Date:  1993

Review 3.  Effects of antihistamine medications on exercise performance. Implications for sportspeople.

Authors:  L C Montgomery; P A Deuster
Journal:  Sports Med       Date:  1993-03       Impact factor: 11.136

4.  Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine.

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

5.  Antihistamines and visual function: studies on dynamic acuity and the pupillary response to light.

Authors:  A N Nicholson; P A Smith; M B Spencer
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

Review 6.  Effects of terfenadine on psychomotor performance. An overview.

Authors:  D W Aaronson
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

7.  EEG and behavioral profile of flutroline (CP-36,584), a novel antipsychotic drug.

Authors:  M Fink; P Irwin
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

8.  Pharmaco-EEG study of 6-azamianserin (ORG 3770): dissociation of EEG and pharmacologic predictors of antidepressant activity.

Authors:  M Fink; P Irwin
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 9.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 10.  Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  E M Sorkin; R C Heel
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.